Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) will present its latest advances in gene therapy for blindness diseases at NobleCon21, the annual emerging growth equity conference hosted by Noble Capital …
Ocugen CEO to Spotlight Gene Therapy Breakthroughs at High-Profile Growth Conference Read More